Health News: [diabetes ]: National Diabetes Volunteer Leadership Council (NDVLC) Urges FDA to Enforce Stringent Accuracy Standards for Blood ...

Yahoo! Health   |  My alerts   |   Edit Alert Monday, Sep 09, 2013 08:11 AM EDT

Health News : diabetes - News from Yahoo !   National Diabetes Volunteer Leadership Council (NDVLC) Urges FDA to Enforce Stringent Accuracy Standards for Blood ... Mon, 09 Sep, 2013 05:00 AM PDT BETHESDA, Md., Sept. 9, 2013 /PRNewswire-USNewswire/ -- Today, representatives from the U.S. Food and Drug Administration (FDA), industry and the diabetes advocacy community will convene at a Diabetes Technology Society meeting in Bethesda, Md., to discuss possible solutions for verifying the ac... Continue reading Boston Therapeutics Closes on Approximately $3.5 Million in Private Placement of Common Stock and Warrants Mon, 09 Sep, 2013 04:00 AM PDT Boston Therapeutics, Inc. , a developer of drugs based on complex carbohydrate chemistry to treat diabetes and inflammatory diseases, has closed on total gross proceeds of approximately $3.5 million to ... Continue reading Boston Therapeutics Closes on Approximately $3.5 Million in Private Placement of Common Stock and Warrants Mon, 09 Sep, 2013 04:00 AM PDT Boston Therapeutics, Inc. , a developer of drugs based on complex carbohydrate chemistry to treat diabetes and inflammatory diseases, has closed on total gross proceeds of approximately $3.5 million to ... Continue reading

Health News : diabetes - Top images.

Health News : diabetes - News from other sources.   1c Mon, 09 Sep, 2013 04:27 AM PDT We aimed to investigate the efficacy and tolerability of empagliflozin, an oral, potent, and selective inhibitor of sodium—glucose co-transporter 2, in patients with type 2 diabetes who had not received drug treatment in the preceding 12 weeks. Continue reading Boston Therapeutics Closes on Approximately $3.5 Million in Private Placement of Common Stock and Warrants Mon, 09 Sep, 2013 04:20 AM PDT Continue reading Boston Therapeutics Closes on Approximately $3.5 Million in Private Placement of Common Stock and Warrants Mon, 09 Sep, 2013 04:12 AM PDT MANCHESTER, NH--(Marketwired - Sep 9, 2013) - Boston Therapeutics, Inc. ( OTCQB : BTHE ) ("Boston Therapeutics" or "the Company"), a developer of drugs based on complex carbohydrate chemistry to treat diabetes and inflammatory diseases, has closed on total gross proceeds of approximately $3.5 million t... Continue reading Non-Profit Organization Taking Control of Your Diabetes (TCOYD) Will Change Lives in Worcester, Massachusetts on ... Mon, 09 Sep, 2013 03:11 AM PDT Dr. Steven V. Edelman is coming to Worcester, Massachusetts' DCU Center with his non-profit organization Taking Control of Your Diabetes (TCOYD) on Saturday, September 21, 2013 for a day that will ignite motivation, offer hope and change the life of anyone with diabetes. (PRWeb September 09, 201... Continue reading

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.